These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 23100622)

  • 61. Innovation in biomedicine: can stem cell research lead the way to affordability?
    Goozner M
    PLoS Med; 2006 Feb; 3(5):e126. PubMed ID: 16492088
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Financing development stage biotechnology companies: RMs vs. IPOs.
    Ahn MJ; Couch RB; Wu W
    J Health Care Finance; 2011; 38(1):32-54. PubMed ID: 22043645
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Amidst scientific unrest, France mulls an institutional alliance.
    Dente K
    Nat Med; 2009 May; 15(5):471. PubMed ID: 19424196
    [No Abstract]   [Full Text] [Related]  

  • 64. Why China needs an NIH.
    Nature; 2004 Apr; 428(6984):679. PubMed ID: 15085093
    [No Abstract]   [Full Text] [Related]  

  • 65. Financing bonanza set to continue.
    Davidson S
    Nat Biotechnol; 2000 Sep; 18(9):922-3. PubMed ID: 10973203
    [No Abstract]   [Full Text] [Related]  

  • 66. U.S. research earmarks. Building a scientific legacy on a controversial foundation.
    Mervis J
    Science; 2008 Jul; 321(5888):480-3. PubMed ID: 18653857
    [No Abstract]   [Full Text] [Related]  

  • 67. Venture Capital Investment in the Life Sciences in Switzerland.
    Hosang M
    Chimia (Aarau); 2014 Dec; 68(12):847-9. PubMed ID: 26508600
    [TBL] [Abstract][Full Text] [Related]  

  • 68. RIKEN--Japan's leading light.
    Nature; 1992 Oct; 359(6396):578. PubMed ID: 1406990
    [No Abstract]   [Full Text] [Related]  

  • 69. Director quits as cash cutbacks hit Californian labs.
    Dalton R
    Nature; 2004 Jan; 427(6972):274. PubMed ID: 14737130
    [No Abstract]   [Full Text] [Related]  

  • 70. [Principles of planning and financing scientific work at the research institutes of the Ministry of Public Health of the Ukrainian SSR under new management conditions].
    Pasechnik SI
    Vrach Delo; 1989 Dec; (12):1-4. PubMed ID: 2697967
    [No Abstract]   [Full Text] [Related]  

  • 71. EU centres saved from 'catastrophe'. European Union.
    Loder N
    Nature; 2000 Mar; 404(6775):217-8. PubMed ID: 10749180
    [No Abstract]   [Full Text] [Related]  

  • 72. Elias Zerhouni.
    Zerhouni E
    Nat Biotechnol; 2011 Mar; 29(3):188. PubMed ID: 21390007
    [No Abstract]   [Full Text] [Related]  

  • 73. French science. Storming the Bastille.
    Balter M
    Science; 2002 Apr; 296(5568):649-51. PubMed ID: 11976428
    [No Abstract]   [Full Text] [Related]  

  • 74. Laying solid foundations for Europe.
    Mattaj IW; Tocchini-Valentini GP
    Nature; 2007 May; 447(7143):377-8. PubMed ID: 17522655
    [No Abstract]   [Full Text] [Related]  

  • 75. Mile-high dreams.
    Cassiday L; Russo G
    Nature; 2010 Jul; 466(7302):146-7. PubMed ID: 20681064
    [No Abstract]   [Full Text] [Related]  

  • 76. Salk: under new management.
    Cohen J
    Science; 1996 Aug; 273(5278):1036-7. PubMed ID: 8711479
    [No Abstract]   [Full Text] [Related]  

  • 77. Biomedical research. Australia pushes stem cell advantage.
    Dayton L
    Science; 2002 Jun; 296(5574):1779-81. PubMed ID: 12052925
    [No Abstract]   [Full Text] [Related]  

  • 78. Bricks and mortar. Rensselaer Polytechnic Institute.
    Russo E
    Nature; 2004 Oct; 431(7010):882. PubMed ID: 15483622
    [No Abstract]   [Full Text] [Related]  

  • 79. Regenerative medicine in Europe: global competition and innovation governance.
    Hogarth S; Salter B
    Regen Med; 2010 Nov; 5(6):971-85. PubMed ID: 21082895
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Introduction to the colloquium].
    Paradeise C
    Med Sci (Paris); 2012; 28 Spec No 2():7-8. PubMed ID: 22759887
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.